Zarir Udwadia
Zarir Udwadia (born 1960) is an Indian pulmonologist and researcher.[1][2][3] His work on drug resistant tuberculosis has led to improvements in India's National Tuberculosis Control Programme.[1][4] Udwadia was the only Indian invited by the WHO to be part of the TB ‘Guidelines Group’, which formulated the 4th edition of the TB Guidelines, published in 2010.[5][6][2] He was also the only doctor to be named among India's best strategists.[7]
Professional life
Udwadia is a graduate of the
Drug-Resistant tuberculosis
Udwadia runs a free weekly TB clinic at the
In December 2011, Udwadia documented twelve cases of what he called totally drug-resistant ('TDR') TB, a strain of the disease that seemed to show resistance to all known treatments.[14][15][16] There were only two other episodes of TDR-TB reported in the world before this- in Iran in 2009, and Italy in 2007.[14][16] Along with his colleagues at the Hinduja Hospital, he published a letter describing four of these cases in the journal Clinical Infectious Diseases.[14] The journal letter prompted extensive media attention. Government officials publicly denied the issue, accused him of wrongly spreading panic, and a Mumbai health official seized patient samples from his laboratory.[13]
While the WHO eventually said that defining resistance beyond XDR-TB was not recommended,[4] Udwadia's research drew the attention of the medical community to the growing epidemic of drug-resistant TB.[1] The coordinator of the WHO's STOP TB department called his findings a wake up call.[16] His research eventually led to improvements in the way TB is managed in India, and elsewhere, and forced the government to make changes to the state-run TB control initiative, or the Revised National Tuberculosis Control Programme.[7] The government increased the budget for the program, and dispatched rapid GeneXpert machines, which can conduct highly sensitive molecular diagnostic testing.[4]
He continues to be an outspoken critic of the government's failures to address the TB problem,[17] and a vocal advocate for newer diagnosis and treatment for TB patients.[13][18][9][3]
References
- ^ a b c d "India's 'tuberculosis warrior'". 2018-03-24. Retrieved 2019-08-25.
- ^ a b Iyer, Malathy. "No more jabs, now new pills to treat TB". Mumbai News. The Times of India. TNN. Retrieved 2019-08-26.
- ^ a b Ubaid, Mir. "The challenges of treating drug-resistant TB in India". www.aljazeera.com. Retrieved 2019-08-26.
- ^ a b c d e "TB Online - The right dose, the right chance: India's battle with drug-resistant TB". www.tbonline.info. Retrieved 2019-08-26.
- ^ a b "'The Ticking Time Bomb': A Doctor on Whether TB Can Be Eliminated from India". The Better India. 2019-04-04. Retrieved 2019-08-25.
- ^ a b c d e "Chest Physician in Mumbai - Dr Zarir F. Udwadia". P.D. Hinduja Hospital. Retrieved 2019-08-25.
- ^ a b "India's best strategists: 15 dreamers who have translated their insight into reality". The Economic Times. Retrieved 2019-08-25.
- ^ "Dr.Zarir Udwadia". TEDxGateway - India's Largest Ideas Platform (Mumbai, India). Retrieved 2019-08-26.
- ^ a b "Scepticism shrouds India's tuberculosis target". Hindustan Times. 2017-12-11. Retrieved 2019-08-26.
- ^ "Dr Zarir F Udwadia | Longitude Prize". longitudeprize.org. Retrieved 2019-08-26.
- ^ Taneja, Richa (2017-08-01). "1 Indian Dies Of Tuberculosis Every Minute, No One Is Immune, Says Expert". Everylifecounts.NDTV.com. Retrieved 2019-08-26.
- ^ "Editorial Board". Thorax. Retrieved 2019-08-25.
- ^ ISSN 0362-4331. Retrieved 2019-08-25.
- ^ S2CID 39443765.
- ^ "TB Online - India: WHO's shorter treatment for multidrug-resistant TB, city may not gain". www.tbonline.info. Retrieved 2019-08-26.
- ^ a b c "Totally drug-resistant TB at large in India". www.newscientist.com. Retrieved 2019-08-26.
- S2CID 52938483.
- ^ "TB Killed Shreya Tripathi, But Her Death Could Have Been Avoided". The Wire. Retrieved 2019-08-26.